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Angiotensin II induces renal oxidant stress in vivo and heme Angiotensin II is incriminated in the pathogenesis of
oxygenase-1 in vivo and in vitro. renal and cardiovascular injury [1–9]. Angiotensin II-
Background. Angiotensin II is strongly incriminated in pro- induced renal injury may arise from its hemodynamic orgressive renal injury. There is recent evidence that angiotensin
nonhemodynamic actions, or from such effects of angio-II induces oxidative stress in vitro. We examined the capacity
tensin II acting in concert [1–6]. Hemodynamic actionsof angiotensin II to induce oxidative stress in vivo and the
functional significance of such stress. The capacity of angioten- include elevation in systemic arterial pressure, alter-
sin II to induce the oxidant-sensitive gene heme oxygenase ations in intraglomerular hemodynamics, and alterations
(HO) in vivo and in vitro was also examined. in interstitial hemodynamics; nonhemodynamic actionsMethods. Angiotensin II was administered via mini-osmotic
of angiotensin II include increased expression of assortedpumps to rats maintained on standard diets. Indices of oxidative
growth factors and protooncogenes, aberrant growth re-stress, including thiobarbituric acid reactive substance, car-
bonyl protein content, and HO activity, were determined. Indi- sponses, and elaboration of inflammatory and fibrogenic
ces of oxidative stress and functional markers were also deter- cytokines [1–7].
mined in the DOCA salt model. The effect of angiotensin II
A nonhemodynamic action of angiotensin II, recentlywas studied in rats maintained on antioxidant-deficient diets
described in smooth muscle cells and relevant to renalso as to examine the functional significance of oxidative stress
induced by angiotensin II. We also explored the inductive effect injury, is the induction of oxidative stress [8, 9]. Such
of angiotensin II on HO in vivo and whether such actions occur oxidative stress in smooth muscle cells may arise from the
in vitro. stimulation of the membrane-bound NADH/NADPH
Results. Angiotensin II administered in vivo increased kid-
oxidase [8, 9], an enzyme also present in endothelialney content of thiobarbituric acid reactive substances protein
cells [10], and which leads to increased generation ofcarbonyl content, and HO activity. These indices were not
present in the kidney of rats treated with DOCA salt for three superoxide anion [8, 9]. Such angiotensin II-induced oxi-
weeks. Such oxidative stress was functionally significant, since dative stress is incriminated in altered vascular responses
the administration of angiotensin II to rats maintained on a that contribute to systemic hypertension and vascularprooxidant diet demonstrated increased proteinuria and de-
injury [8–13]. Thus, the stimulation of reactive oxygencreased creatinine clearance. The stimulatory effect on HO
species represents an action of angiotensin that, whileactivity was due to induction of HO-1 mRNA, with HO-2
mRNA remaining unchanged. Expression of HO-1 was local- “nonhemodynamic” in terms of its biochemical origin,
ized to the renal proximal tubules in vivo. We also demonstrate interfaces with and relates to the hemodynamic effects
that angiotensin II at concentrations of 1028 and 1027 mol/L of angiotensin II.induces expression of HO-1 mRNA in LLC-PK1 cells.
More recently, a similar oxidative effect of angiotensinConclusions. Angiotensin II induces oxidative stress in vivo,
II has been described in mesangial cells and LLC-PK1which contributes to renal injury. This study also demonstrates
that angiotensin II induces renal HO activity caused by up- cells in vitro [14, 15]. Besides being present in endothelial
regulation of HO-1 in renal proximal tubules. Finally, angioten- and smooth muscle cells, a membrane-bound NADPH/
sin II directly induces HO-1 in renal proximal tubular epithelial
NADH oxidase is also present in cells intrinsic to thecells in vitro.
kidney such as mesangial cells [16], glomerular podocytes
[17], and proximal tubular epithelial cells [18]. In re-
1 See Editorial by Meyer, p. 458 sponse to angiotensin II, mesangial and LLC-PK1 cells
demonstrate increased production of superoxide anionKey words: renal tubule, chronic renal injury, systemic hypertension,
proteinuria, hemodynamics. emanating from induced NADPH/NADH activity [14, 15];
such biochemical responses influence cellular prolifera-Received for publication August 6, 1999
tion in vitro and are inferentially linked to the role ofand in revised form January 25, 2000
Accepted for publication February 2, 2000 angiotensin II in progressive renal disease [14, 15].
In the present study, we questioned whether angioten-Ó 2000 by the International Society of Nephrology
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sin II induces oxidative stress in vivo in the kidney and function and systolic blood pressure were determined
after three weeks.whether such oxidant stress may be incriminated in renal
injury induced by angiotensin II in vivo. In the course
Chronic administration of angiotensin II in ratsof these studies and as an index of oxidative stress, we
maintained on diets deficient in antioxidantsexamined the effect of angiotensin II on heme oxygenase
(HO) activity. HO exists in at least two isoforms, HO-1 To examine the functional effects of angiotensin II-
induced oxidative stress, the effects of angiotensin IIand HO-2 [19, 20]. HO-1 is widely induced by oxidative
stress, cytokines, heavy metals, advanced-glycated end were studied in rats maintained on a diet deficient in
vitamin E and selenium [21, 23]; this dietary deficiencyproducts, while the constitutive isoform, HO-2, is in-
duced by a quite limited number of stimuli that includes uncovers the functional effects of oxidative phenomena
since deficiency of selenium impairs glutathione peroxi-glucocorticoids [19, 20]. We thus examined the basis for
the induction of HO activity and localized the site within dase-dependent scavenging of H2O2, while vitamin E de-
ficiency removes the endogenous antioxidant in lipid bi-the kidney where such induction occurred.
layers in plasma and intracellular membranes. Weanling
rats were placed on vitamin E and selenium-deficient
METHODS
and control diets, and mini-osmotic pump placement was
Chronic administration of angiotensin II performed two weeks following the initiation of this diet.
by mini-osmotic pump Angiotensin II was delivered at a rate of 200 ng/min/
300 g body weight for two weeks. In additional studies,Angiotensin II (Sigma, St. Louis, MO, USA) was ad-
ministered to male Sprague-Dawley rats subcutaneously weanling rats were maintained on the control and defi-
cient diets for two weeks and were then subjected tovia mini-osmotic pumps (Alzet Corp., Palo Alto, CA,
USA) at two different doses [2]. Rats were maintained administration of vehicle infused at an identical rate via
mini-osmotic pumps for two weeks.on standard rat chow (Ralston Purina Co., St. Louis, MO,
USA) and tap water ad libitum. The higher dose protocol
Indices of oxidative stressadministered angiotensin II at 200 ng/min/300 g body
weight for up to two weeks, while the lower dose protocol Three indices of oxidative stress were employed: lipid
peroxidation, protein carbonyl content, and activity ofused angiotensin II at 60 ng/min/300 g body weight for
four weeks. Angiotensin II was dissolved in lactated the oxidant-inducible enzyme HO. Lipid peroxidation
was determined by measurement of thiobarbituric acidRinger’s solution and loaded into two- or four-week
mini-osmotic pumps according to the recommendations reactive substances (TBARS), as described in our previ-
ous studies [23]. HO activity was determined in kidneyof the manufacturer. These pumps, containing angioten-
sin II or vehicle, were placed into subcutaneous tissue microsomes in which the rate of formation of bilirubin
was assayed, as previously described [24]. Protein car-via a midscapular incision in rats anesthetized with Meth-
ohexitol (50 mg/kg body weight), the latter administered bonyl content was determined by the method based on
2,4-dinitrophenylhydrazine (DNPH) [25]. A soluble pro-intraperitoneally. Rats were subsequently housed indi-
vidually for one week to prevent pump loss. In these and tein fraction of the kidney was separated into aliquots
that were incubated for one hour with either 2 mol/Lother studies, systolic blood pressures were measured in
awake, restrained rats via tail cuff plethysmography [21]. HCl or 10 mmol/L 2,4-DNPH dissolved in 2 mol/L HCl.
Following precipitation with trichloroacetic acid, the pel-Twenty-four-hour metabolic collections were obtained
in a standard fashion, and urinary concentration of pro- let was washed and then dissolved in guanidine hydro-
chloride. The difference in absorbance between samplestein was determined by the Coomassie method [21]. Con-
centrations of creatinine in serum and urine were ana- treated with 2,4-DNPH in 2 mol/L HCl, and the sample
treated with 2 mol/L HCl alone was determined at 366lyzed using a Beckman II Creatinine Analyzer [21].
nmol. Data are expressed as nanomoles of carbonyl
Model of systemic hypertension induced by DOCA salt groups per milligram of protein.
Uninephrectomy was performed in male Sprague
Expression of HO-1 and HO-2 by Northern analysisDawley rats anesthetized with intraperitoneal methohex-
ital (50 mg/kg body weight). After uninephrectomy, rats Total RNA from rat kidney and from cultured cells
was isolated using a modification of the guanidinium-were allowed to drink normal saline and were injected
weekly with deoxycorticosterone acetate (DOCA) in ol- isothiocyanate/cesium chloride method, and Northern
blot analysis was performed, as previously describedive oil (10 mg/rat) administered subcutaneously [22];
sham-nephrectomized rats received tap water. After [23, 24]. Aliquots (20 mg) of total RNA were separated
by electrophoresis. Autoradiograms were quantitated bythree weeks, rats were sacrificed for the determination
of indices of renal oxidative stress. In additional cohorts computer-assisted videodensitometry, and results were
standardized by the method of Correa-Rotter, Mariash,of DOCA salt-treated and control rats, indices of renal
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Table 1. Functional effects of angiotensin II administered by mini-and Rosenberg [26]. This established method of stan-
osmotic pump (200 ng/min/300 g body wt)
dardization corrects for any variability due to loading
Vehicle Angiotensin IIand transfer, and factors the optical density of the mes-
(N 5 12) (N 5 10)sage for the given gene with the optical density of the 18S
Body weight g 27165 208612arRNA, the latter obtained on a negative of the ethidium
CCr mL/min 3.0460.25 1.5260.14abromide-stained nylon membrane. Northern analyses CCr/100 g body weight 1.1360.10 0.7560.08a
Proteinuria mg/24 hr 2262 105612awere undertaken using cDNA probes for mouse HO-1
Blood pressure mm Hg 13464 220610aand human HO-2 [23, 24].
Data are means 6 SEM. CCr is creatinine clearance.
aP , 0.05 vs. vehicleExpression of HO-1 by immunohistochemical analysis
Immunohistochemical analysis was performed as pre-
viously described on tissue sections fixed in 10% neutral
buffered formalin and embedded in paraffin [27]; expres- clearance (Table 2). Such doses of angiotensin II also
imposed oxidative stress on the kidney in vivo, as indi-sion of HO-1 was localized using a monoclonal antibody
(OSA-111; Stressgen, Victoria, BC, Canada) as the pri- cated by significant elevations in TBARS and HO activ-
ity; however, protein carbonyl content was not increasedmary antibody, a polyclonal goat anti-mouse IgG as the
secondary antibody (SAB-100; Stressgen), and diamino- (Fig. 2).
benzidine as substrate for localization.
Renal oxidative stress in the DOCA salt model of
hypertension and renal injuryExpression of HO-1 in LLC-PK1 cells exposed
to angiotensin II To determine whether oxidative stress occurs in the
kidney in another model of systemic hypertension andLLC-PK1 cells were maintained in culture in Dulbec-
co’s modified Eagle’s medium (DMEM) with 10% fetal renal injury, we measured these three indices in the kid-
ney in a model of hypertension that is considered angio-bovine serum, as previously described [28]. Cells were
seeded onto 15 cm plates and grown to approximately tensin II-independent, namely, the DOCA salt model.
Systolic blood pressure and indices of renal function and60% confluency. Media were replaced by serum-free
DMEM for 24 hours, after which cells were incubated other alterations in the DOCA salt model are summa-
rized in Table 3. As shown, this model demonstratedin either serum-free DMEM alone or DMEM containing
1028 or 1027 mol/L angiotensin II for 48 hours. After marked elevation in systolic blood pressure, markedly
increased rates of urinary protein excretion, and a reduc-the first 24 hours, the media were replaced with freshly
prepared media containing angiotensin II or the control tion in creatinine clearance. Statistical analyses by analy-
sis of variance of these parameters in the DOCA saltmedium. RNA was subsequently extracted from these
cells. model (Table 3) and in rats subjected to the higher dose
of angiotensin II (Table 1) demonstrated that systolic
Statistics blood pressures, rates of urinary protein excretion, and
creatinine clearances (absolute or factored for bodyData are expressed as means 6 SEM. For comparison
of two groups, the unpaired Student t-test or the Mann– weight) were not significantly different in angiotensin II-
infused and DOCA salt-treated rats. In additional co-Whitney test was used as appropriate. Values are consid-
ered statistically significant for P , 0.05. horts of DOCA salt-treated and control rats, indices of
oxidative stress, including HO activity, were measured
after three weeks. As depicted in Figure 3, none of these
RESULTS
indices were elevated. Thus, at this time point in this
Effect of angiotensin II on renal function and renal model, oxidant stress does not occur despite markedly
oxidative stress elevated systolic blood pressure and proteinuria and de-
creased creatinine clearance.Administration of the higher dose of angiotensin II
significantly increased systolic blood pressure and uri-
Functional effect of chronic angiotensin II infusionnary protein excretory rates and significantly decreased
in rats maintained on an antioxidant-deficient dietcreatinine clearance (Table 1). Such doses of angiotensin
II imposed oxidative stress on the kidney in vivo in that To determine the functional effect of increased oxida-
tive stress imposed by angiotensin II in vivo, the effectall markers of oxidative injury—TBARS, protein car-
bonyl content, and the activity of the oxidant-sensitive of angiotensin II was examined in rats maintained on a
diet deficient in antioxidants. The baseline body weight,enzyme, HO—were significantly increased (Fig. 1).
Administration of the lower dose of angiotensin II creatinine clearance, urinary protein excretory rates, and
systolic blood pressure in control rats and rats main-significantly increased urinary protein excretion and sys-
tolic blood pressure while tending to decrease creatinine tained on the deficient diets were not significantly differ-
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Fig. 1. Effect of angiotensin II ( ; 200 ng/min/300 g body weight; N 5 8) or vehicle (h; N 5 7) infused by mini-osmotic pump on indices of
oxidative stress (TBARS, HO activity, and protein carbonyl content) in the kidney (*P , 0.05).
Table 2. Functional effects of angiotensin II administered by mini- Table 3. Functional studies in control and DOCA salt-treated rats
osmotic pump (60 ng/min/300 g body weight)
Control DOCA salt
Vehicle Angiotensin II (N 5 6) (N 5 7)
(N 5 6) (N 5 8)
Body weight g 34766 321612
Body weight g 34669 31465a CCr mL/min 3.0060.17 1.9960.15a
CCr mL/min 2.9760.25 2.4860.08 CCr/100 g body weight 0.8760.05 0.6560.04a
CCr/100 g body weight 0.8760.08 0.7960.03 Proteinuria mg/24 hr 2362 3416116a
Proteinuria mg/24 hr 4369 107626a Blood pressure mm Hg 13362 19466a
Blood pressure mm Hg 13463 21267a
Data are means 6 SEM. CCr is creatinine clearance.
aP , 0.05 vs. vehicleData are means 6 SEM. CCr is creatinine clearance.
aP , 0.05 vs. vehicle
Fig. 2. Effect of angiotensin II ( ; 60 ng/min/300 g body weight; N 5 8) and vehicle (h; N 5 6) infused by mini-osmotic pump on indices of
oxidative stress (TBARS, HO activity, and protein carbonyl content) in the kidney (*P , 0.05).
Haugen et al: Angiotensin II and renal oxidant stress148
Fig. 3. Indices of oxidative stress (TBARS (A), HO activity (B), and protein carbonyl (C ) content) in the kidney in the DOCA salt model.
Symbols are: (h) Control, N 5 5; ( ) DOCA salt, N 5 8. P 5 NS.
Table 5. Functional parameters in rats maintained on control andTable 4. Functional parameters in rats maintained on control and
deficient diets infused with angiotensin II by mini-osmotic pump deficient diets infused with vehicle by mini-osmotic pump
Control diet Deficient dietControl diet Deficient diet
(N 5 8) (N 5 10) (N 5 6) (N 5 6)
Body weight g 18765 17065aBody weight g 15965 13665a
CCr mL/min 1.2060.06 0.7960.07a CCr mL/min 1.960.2 1.760.3
CCr/100 g body weight 1.060.1 1.060.2CCr/100 g body weight 0.7560.04 0.5860.06a
Proteinuria mg/24 hr 4.861.9 20.665.1a Proteinuria mg/24 hr 1.960.2 1.360.2
Data are means 6 SEM. CCr is creatinine clearance. Data are means 6 SEM. CCr is creatinine clearance.
aP , 0.05 vs. control dietaP , 0.05 vs. control diet
ent (data not shown). The infusion of angiotensin II induction of HO-1 contributed to such increments. HO
consists of at least two isoforms: the oxidant-induciblediminished creatinine clearances (expressed in absolute
terms or factored for body weight) and increased urinary one, HO-1, and the constitutively expressed isoform,
HO-2. We thus determined which of these two isoformsprotein excretory rates in rats maintained on the defi-
cient diets (Table 4). These effects were due to angioten- were induced. Northern analyses demonstrated a striking
induction in HO-1 in the kidney following the infusionsin II imposed in the setting of this dietary manipulation
since rats maintained on the control and deficient diets of angiotensin II: HO-1 mRNA was increased sevenfold
(1.4 6 0.2 vs. 9.7 6 1.6, standardized OD units, P ,demonstrated comparable creatinine clearances and uri-
nary protein excretory rates when vehicle was infused 0.05; Fig. 4). In these studies, no increment in HO-2
mRNA was observed in the kidney (5.0 6 0.8 vs. 5.0 6over a similar time period (Table 5).
Systolic blood pressure was measured on days 4, 8, 0.5, OD units, P 5 NS; data not shown).
The site of induction of HO-1 was localized by immu-11, and 14 after the administration of angiotensin II in
rats maintained on the control and deficient diets. There nohistochemical analyses (Fig. 5). Vehicle-infused rats
demonstrated no induction of HO-1 in the kidney (Fig.were no differences between the groups except on the
final measurement (day 14) when systolic blood pres- 5A), whereas the kidneys in rats infused with angiotensin
II demonstrated marked induction of HO-1, which local-sures in rats on the deficient diet were marginally higher,
albeit significantly so, as compared with such pressures ized largely to renal proximal tubules (Fig. 5B).
in rats on the control diet and infused with angiotensin
Induction of HO-1 in renal epithelial cells in vitroII (188 6 6 vs. 217 6 9 mm Hg, P , 0.05).
by angiotensin II
Induction of HO-1 in the kidney in vivo To determine whether angiotensin II exerts a direct
by angiotensin II inductive effect on cellular expression of HO-1 mRNA
the gene expression was evaluated in LLC-PK1 cellsWe further examined the induction of HO by angio-
tensin II in the kidney, specifically, questioning whether exposed to angiotensin II in vitro during conditions that
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Fig. 4. Heme oxygenase-1 (HO-1) mRNA
expression in the kidney in rats subjected to
vehicle or angiotensin II (Ang II; 200 ng/min/
300 g body weight) infused by mini-osmotic
pump. Each lane represents mRNA extracted
from a single kidney from an individual rat.
The individual and mean standardized densi-
tometric readings are provided below the
Northern analysis.
Fig. 6. HO-1 mRNA in LLC-PK1 cells exposed to angiotensin II at
increasing concentrations. Each lane represents mRNA extracted from
an individual plate under the stated conditions: Control, angiotensin
II (Ang II) at concentrations of 1028 and 1027 mol/L. The individual
and mean standardized densitometric readings are provided below the
Northern analysis.
stress in the kidney. These data complement the recent
demonstration that the exposure of mesangial cells [14]
or renal epithelial cells such as LLC-PK1 [15] to angio-
tensin II induces oxidative stress in vitro because of in-
duction of NADH/NADPH oxidase.
Angiotensin II exerts effects on the kidney that are
ascribable to hemodynamic and nonhemodynamic ac-
tions, and both actions contribute to the involvement of
angiotensin II in progressive renal injury [1–6]. In an
attempt to determine the specificity of angiotensin II
per se or the effects induced by angiotensin II in vivo
(systemic hypertension, proteinuria, and reduced creati-
nine clearance) in provoking oxidant stress, we examined
indices of oxidative stress in the DOCA salt model of
systemic hypertension, one in which such functional
changes occur in a setting in which angiotensin II is system-
Fig. 5. Localization of HO-1 expression by immunoperoxidase in the ically suppressed. As shown in Table 3, the DOCA salt
kidney in rats subjected to vehicle (A) or angiotensin II (200 ng/
model, when studied at three weeks, exhibits elevationsmin/300 g body weight; B) infused by mini-osmotic pump. Original
magnification 3200. in systolic blood pressure, reductions in creatinine clear-
ance, and elevations in urinary protein excretion, which
are all comparable to that observed in the angiotensin
II-infused rats. Thus, indices of oxidative stress in thevaried the concentrations of angiotensin II and the dura-
DOCA salt model studied after three weeks remainedtion of exposure. Exposure of LLC-PK1 cells to angio-
unaltered in the face of marked systemic hypertension,tensin II at concentrations of 1028 and 1027 mol/L for 48
proteinuria, and diminished GFR. Nevertheless, it musthours induced a 2.3-fold in HO-1 (Fig. 6).
be pointed out that these findings do not negate a role
for systemic hypertension or proteinuria in inducing oxi-
DISCUSSION dative stress and HO-1, since it is possible that exposure
to DOCA salt for a period longer than three weeks mayUsing diverse markers of oxidative injury—an index
be required to evince such effects. It is conceivable thatof oxidation of lipid (TBARS), an index of protein oxida-
at time points later than three weeks, when renal injurytion (carbonyl content), and the induction of a redox-
is more established, indices of oxidative stress and induc-sensitive enzyme (HO)—we provide evidence that the
administration of angiotensin II in vivo induces oxidative tion of HO may occur in the DOCA salt model. It is
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also possible that these alterations in blood pressure and oxidase system and attendant generation of superoxide
anion. For example, angiotensin II markedly increasesproteinuria may exert oxidative stress and expression of
HO-1, but such effects may require the presence of cer- urinary excretion of proteins, and among the latter are
transferrin and other transition metal-bearing proteinstain “threshold” amounts of angiotensin II. The latter
may not be present in the DOCA salt model since it is [29]; such transition metals as iron and copper are potent
catalysts for oxidative stress [30]. Additionally, angioten-associated with systemic suppression of angiotensin II.
To examine the functional significance of oxidative sin II may stimulate the elaboration of a number of
cytokines, many of which are prooxidant [6, 31, 32].stress induced by angiotensin II, the effects of angioten-
sin II were studied in a dietary deficiency state in which Generation of reactive oxygen species by angiotensin
II may contribute to progressive renal injury throughthe kidney is rendered prooxidant. The application of a
diet deficient in vitamin E and selenium promotes a diverse mechanisms [31–33]. By their vasoactive effects
on the afferent and efferent arterioles and the mesan-prooxidative state through the following mechanisms
[21, 23]. Selenium is a cofactor for glutathione peroxi- gium, oxidants may induce glomerular hemodynamic al-
terations, which contribute to progressive renal disease.dase, one of the two hydrogen peroxide-degrading en-
zymes (the other being catalase), and vitamin E is the Oxidants can compromise glomerular permselective prop-
erties, thereby leading to increased urinary excretion ofmajor antioxidant resident in lipid bilayers. Thus, a com-
bined deficiency of these two dietary constituents fosters proteins; this latter alteration may be damaging to the
renal tubular epithelium [30]. Relevant to these consider-the accumulation of hydrogen peroxide and its attendant
effects on lipid bilayers as well as other cellular effects. ations is our finding that proteinuria was greater, and
creatinine clearance was lower, following the chronicThis dietary manipulation was employed at a sufficiently
early stage such that the recognized adverse effects of administration of angiotensin II in rats on the deficient
diet as compared with those on the control diet. Suchthis dietary deficiency per se on creatinine clearance
and proteinuria were not evinced. Chronic infusion of findings suggest that oxidative stress arising from angio-
tensin II may influence renal hemodynamics and glomer-angiotensin II lowered creatinine clearance and increased
urinary protein excretion in rats maintained on the defi- ular permselective properties. Oxidants can exert direct
cytotoxicity to cells in the glomerular, vascular, and tubulo-cient diet as compared with rats on the control diets.
These parameters were not different in rats on these interstitial compartments. Additionally, there is mounting
evidence that key steps in the elicitation of an inflamma-diets prior to the initiation of angiotensin II, nor were
these parameters different in vehicle-infused rats main- tory response may be up-regulated by oxidants [31–33]:
Activation of endothelial and epithelial cells and the elab-tained on the control and deficient diets. Thus, the oxida-
tive effect of angiotensin II appears functionally signifi- oration of proinflammatory and chemotactic substances
may also be induced by oxidants. More specifically, adhe-cant since indices of injury—creatinine clearance and
proteinuria—are exacerbated by angiotensin II in kid- sion molecules (intercellular adhesion molecule-1 and vas-
cular cellular adhesion molecule-1), selectins (E-selectin,neys rendered prooxidant.
Rates of urinary protein excretion in response to P-selectin), the T-cell chemoattractant (RANTES), the
monocyte chemoattractant (MCP-1), and the fibrogenicchronic administration of angiotensin II were lower in
rats maintained on the control diets (antioxidant suffi- cytokine (transforming growth factor-b1), may be up-
regulated by oxidative stress [31–33]. Indeed, the tran-cient diet) in the antioxidant-deficiency study (Table 4)
as compared with rats on standard Purina rat chow (Ta- scription factor that is involved in the up-regulation of
numerous proinflammatory species, namely, nuclear fac-ble 1). The compositions of these diets differ markedly
in many constituents. For example, the control diet for tor-kB (NF-kB), can be induced by oxidative stress [31, 33].
Interestingly, several of these participants in inflamma-the antioxidant deficiency study contains lower amounts
of protein than Purina rat chow and is based on a differ- tion, in particular, NF-kB, are inducible by angiotensin
II [6, 34–36]; and in models of immune complex nephritisent protein source, Torula yeast. These and other differ-
ences in dietary composition contribute to the lower and antiglomerular basement disease, pathogenetic roles
have been recently assigned to angiotensin II [36, 37].rates of urinary protein excretion in response to angio-
tensin II. Additionally, rats used in the antioxidant-defi- Thus, angiotensin II—physiology’s archetypal, vasoact-
ive substance—is now regarded as a promoter of in-ciency study were younger and lighter in weight, the
latter consideration leading to a lesser absolute amount flammatory and immune renal injury. Such effects of
angiotensin II may reflect, at least in part, the prooxidantof angiotensin II being infused in the antioxidant-defi-
ciency study. Such differences, in addition to those per- actions of angiotensin II.
Heme oxygenase-1 was employed as a marker of oxi-taining to the respective diets, underlie the differences
in urinary protein excretion. dative stress in light of the recent evidence that the infu-
sion of angiotensin II induces HO-1 in the vasculatureAngiotensin II may induce oxidant stress via other
mechanisms besides activation of the NADPH/NADH [38]. Extrapolating from the recognized effects of HO
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in other systems [19, 20], it is possible that such induction the expression of a number of genes relevant to tissue
injury, reparative responses, and inflammation. It is pos-in the vasculature may confer antioxidant, anti-inflam-
matory, and vasodilatory properties. Our studies demon- sible that proteinuria induced by angiotensin II may con-
strate marked increments in HO activity in the kidneys tribute to the up-regulation of HO-1 in the renal proxi-
of rats subjected to angiotensin II infusion. Such increased mal tubule in vivo.
HO activity may reflect either increments in HO-1, In summary, we provide evidence that angiotensin II
HO-2, or both. HO is the isozyme induced by a number is a potent inducer of oxidative stress in the kidney in
of stimuli, many of which share the common effect of vivo, and such oxidative stress is functionally relevant
influencing cellular redox; HO-2 is the constitutively ex- to the renal effects of angiotensin II. Moreover, angio-
pressed isozyme [19, 20]. We demonstrate that the in- tensin II strongly induces the expression of HO-1 in the
crease in HO activity is due to HO-1 since Northern kidney, an effect emanating, at least in part, from direct
analyses revealed induction of HO-1 mRNA without any actions of angiotensin II on the renal proximal tubule.
significant change in HO-2 mRNA. Additional support
for the induction of HO-1 as the basis for increased HO ACKNOWLEDGMENTS
activity was provided by immunohistochemical studies These studies were funded by an RO1 DK47060 (K.A.N.). We
in which the localization of HO-1 was undertaken. In gratefully acknowledge the secretarial expertise of Mrs. Sharon Hep-
pelmann in the preparation of this manuscript.these studies, induction of HO-1 was observed largely
in the proximal tubules in animals infused with angioten- Reprint requests to Dr. Karl Nath, Mayo Clinic, 200 First Street, SW,
sin II. The functional significance of the expression of 542 Guggenheim Building, Rochester, Minnesota 55905, USA.
E-mail: nath.karl@mayo.eduHO-1 in the kidney in vivo in response to angiotensin
II invites certain speculations. Such induction of HO-1
REFERENCESmay represent an antioxidant response that mitigates the
severity of oxidative stress and attendant injury induced 1. Lafayette RE, Mayer G, Park SK, Meyer TW: Angiotensin II
receptor blockade limits glomerular injury in rats with reducedby angiotensin II [19, 20]. It is also possible that the
renal mass. J Clin Invest 90:766–771, 1992expression of HO-1 in response to the administration of
2. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P,
angiotensin II in vivo represents an anti-inflammatory Floege J, Schwartz SM: Renal injury from angiotensin II-medi-
ated hypertension. Hypertension 19:464–474, 1992response that limits the extent of inflammation induced
3. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH: Theby angiotensin II [19, 20, 39].
paradox of the renin-angiotensin system in chronic renal disease.
To determine whether angiotensin II would directly Kidney Int 45:403–410, 1994
4. Harris RC, Cheng HF: The intrarenal renin-angiotensin system:elicit such effects in renal epithelial cells, we studied
A paracrine system for the local control of renal function separateproximal tubular epithelial cells in culture exposed to
from the systemic axis. Exp Nephrol 4(Suppl 1):2–7, 1996
angiotensin II. Under certain conditions, we observed 5. Anderson S: Physiologic actions and molecular expression of the
more than a twofold induction of HO-1 in response to renin-angiotensin system in the diabetic rat. Miner Electrolyte
Metab 24:406–411, 1998angiotensin II. These findings are of significance, in that
6. Klahr S, Morrissey J: Angiotensin II and gene expression in thethey demonstrated direct effects of angiotensin II on kidney. Am J Kidney Dis 31:171–176, 1998
expression of HO-1 by proximal tubular epithelial cells, 7. Pratt RE: Angiotensin II and the control of cardiovascular struc-
ture. J Am Soc Nephrol 10:S120–S128, 1999and they complement our localization of the expression
8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW:of HO-1 in rat proximal tubules in response to angioten- Angiotensin II stimulates NADH and NADPH oxidase activity
sin II administered in vivo. These findings are in contrast in cultured vascular smooth muscle cells. Circ Res 74:1141–1148,
1994to studies of expression of HO-1 in smooth muscle cells
9. Rajagopalan S, Kurz S, Mu¨nzel T, Tarpey M, Freeman BA,in vitro, wherein angiotensin II suppresses expression of Griendling KK, Harrison DG: Angiotensin II-mediated hyper-
HO-1 by smooth muscle cells [40]. To the extent that tension in the rat increases vascular superoxide production via
membrane NADH/NADPH oxidase activation. J Clin Investexpression of HO-1 localizes the compartment within
97:1916–1923, 1996the kidney experiencing the oxidative effects of infused 10. Jones SA, O’Donnell VB, Wood JD, Broughton JP, Hughes
angiotensin II, our studies indicate that oxidant stress EJ, Jones TO: Expression of phagocyte NADPH oxidase compo-
nents in human endothelial cells. Am J Physiol 271:H1626–H1634,exerted by angiotensin II infused in vivo is borne largely
1996by the proximal tubular compartment. Studies using the
11. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA,
receptor blockers would be of interest in cells in culture Harrison DG: Role of superoxide in angiotensin II-induced but
not catecholamine-induced hypertension. Circulation 95:588–593,exposed to angiotensin II so as to determine angiotensin
1997II receptor-specific actions underlying such expression
12. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling
of HO-1. It is also possible that the induction of HO-1 KK: p22phox is a critical component of the superoxide-generating
NADH/NADPH oxidase system and regulates angiotensin II-in vivo in the renal proximal tubular compartment may
induced hypertrophy in vascular smooth muscle cells. J Biol Chemreflect the functional effects of proteinuria induced by
271:23317–23321, 1996
angiotensin II. Increased trafficking of protein across 13. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison
DG, Taylor WR, Griendling KK: Role of NADH/NADPH oxi-and through the proximal tubule can markedly influence
Haugen et al: Angiotensin II and renal oxidant stress152
dase-derived H2O2 in angiotensin II-induced vascular hypertrophy. transfer control for Northern hybridization. Biotechniques 12:154–
158, 1992Hypertension 32:488–495, 1998
27. Vogt BA, Shanley TP, Croatt AJ, Alam J, Johnson KJ, Nath14. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superox-
KA: Glomerular inflammation induces resistance to tubular injuryide anion production by mesangial cells. Kidney Int 54:775–784,
in the rat: A novel form of acquired heme oxygenase-dependent1998
resistance to renal injury. J Clin Invest 98:2139–2145, 199615. Hanken T, Schroeder R, Stahl RAK, Wolf G: Angiotensin II-
28. Nath KA, Enright H, Nutter L, Fischereder MF, Zou JN, Heb-mediated expression of p27Kip1 and induction of cellular hypertro-
bel RP: Effect of pyruvate on oxidant injury to isolated and cellularphy in renal tubular cells depend on the generation of oxygen
DNA. Kidney Int 45:166–176, 1994radicals. Kidney Int 54:1923–1933, 1998
29. Alfrey AC, Hammond WS: Renal iron handling in the nephrotic16. Radeke HH, Cross AR, Hancock JT, Jones OTG, Nakamura
syndrome. Kidney Int 37:1409–1413, 1990M, Kaever V, Resch K: Functional expression of NADPH oxidase
30. Nath KA: Tubulo-interstitial disease as a major determinant ofcomponents (a- and b-subunits of cytochrome b558 and 45-kDa
progressive renal injury. Am J Kidney Dis 20:1–17, 1992flavoprotein) by intrinsic human glomerular mesangial cells. J Biol
31. Schlondorff D: The role of chemokines in the initiation andChem 266:21025–21029, 1991
progression of renal diseases. Kidney Int 49:S44–S47, 199517. Greiber S, Mu¨nzel T, Ka¨stner S, Mu¨ller B, Schollmeyer P,
32. Shah SV: The role of reactive oxygen metabolites in glomerularPavensta¨dt H: NAD(P)H oxidase activity in cultured human po-
disease. Annu Rev Physiol 57:245–262, 1995docytes: Effects of adenosine triphosphate. Kidney Int 53:654–663,
33. Haugen E, Nath KA: The involvement of oxidative stress in the1998
progression of renal injury. Blood Purif 17:58–65, 199918. Cui X-L, Douglas JG: Arachidonic acid activates c-jun N-terminal
34. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin IIkinase through NADPH oxidase in rabbit proximal tubular epithe-
stimulates extracellular matrix protein synthesis through inductionlial cells. Proc Natl Acad Sci USA 94:3771–3776, 1997
of transforming growth factor-b expression in rat glomerular mes-19. Nath KA, Agarwal A, Vogt B: Functional consequences of induc-
angial cells. J Clin Invest 93:2431–2437, 1994tion of heme oxygenase in Contemporary Issues in Nephrology: 35. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wen-Acute Renal Failure: Emerging Concepts and Therapeutic Strate- zel U, Zahner G, Helmchen U, Stahl RAK: Angiotensin II
gies, edited by Goligorsky MS, Stein J, New York, Edinburgh, stimulates expression of the chemokine RANTES in rat glomerular
Churchill Livingstone, 1995, pp 97–118 endothelial cells. J Clin Invest 100:1047–1058, 1997
20. Platt JL, Nath KA: Heme oxygenase: Protective gene or Trojan 36. Ruiz-Ortega M, Bustos C, Herna´ndez-Presa MA, Lorenzo O,
horse. Nat Med 4:1364–1365, 1998 Plaza JJ, Egido J: Angiotensin II participates in mononuclear cell
21. Nath KA, Salahudeen AK: Induction of renal growth and injury recruitment in experimental immune complex nephritis through
in the intact rat kidney by dietary deficiency of antioxidants. J Clin nuclear factor-kB activation and monocyte chemoattractant
Invest 86:1179–1192, 1990 protein-1 synthesis. J Immunol 161:430–439, 1998
22. Dworkin LD, Hostetter TH, Rennke HG, Brenner BM: Hemo- 37. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H,
dynamic basis for glomerular injury in rats with desoxycorticoste- Sakurai H, Fukamizu A, Murakami K: Angiotensin II plays a
rone-salt hypertension. J Clin Invest 73:1448–1461, 1984 pathogenic role in immune-mediated renal injury in mice. J Clin
23. Nath KA, Grande JP, Croatt AJ, Haugen JD, Kim Y, Rosenberg Invest 103:627–635, 1999
ME: Redox regulation of renal DNA synthesis, TGFb1 and colla- 38. Ishizaka N, Leo´n H, Laursen JB, Fukui T, Wilcox JN, De Keu-
gen gene expression. Kidney Int 53:367–381, 1998 lenaer G, Griendling KK, Alexander W: Angiotensin II-
24. Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt induced hypertension increases heme oxygenase-1 expression in
MD, Rosenberg ME: Induction of heme oxygenase is a rapid, rat aorta. Circulation 96:1923–1929, 1997
protective response in rhabdomyolysis in the rat. J Clin Invest 39. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ:
90:267–270, 1992 Induction of heme-oxygenase-1 inhibits the monocyte transmigra-
25. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz tion induced by mildly oxidized LDL. J Clin Invest 100:1209–1216,
AG, Ahn BW, Shaltiel S, Stadtman E: Determination of car- 1997
bonyl content in oxidatively modified proteins. Methods Enzymol 40. Ishizaka N, Griendling KK: Heme oxygenase-1 is regulated by
186:464–478, 1990 angiotensin II in rat vascular smooth muscle cells. Hypertension
29:790–795, 199726. Correa-Rotter R, Mariash CN, Rosenberg ME: Loading and
